Merck whistleblower lawsuit

    • Investor Relations | Akorn, Inc.

      The acquisition included our acquisition of a Merck subsidiary corporation, Inspire Pharmaceuticals, Inc. (“Inspire”), which was and continues to be the holder of the product rights to AzaSite®. ... pursuant to the False Claims Act’s whistleblower or . qui tam. ... the Attorney General of the State of Louisiana filed a lawsuit against Hi ...


    • Investor Relations | RAPT Therapeutics, Inc.

      If Merck were to terminate our collaboration agreement, we may be forced to purchase pembrolizumab to continue our current and planned clinical trials or to pursue another anti-PD-1 therapy for co-administration with FLX475 in place of pembrolizumab, which may require us to restart preclinical studies or clinical trials, any of which could ...


    • [DOCX File]29 - Veterans Resources - A community for military veterans

      https://info.5y1.org/merck-whistleblower-lawsuit_1_85d8ce.html

      Whistleblower cases usually allege that an officer or superior has retaliated against a lower ranking service member or worker for making some type of complaint. According to Fine, the number of retribution complaints filed against senior officials increased from 145 to 165 over the past five years.


    • [DOC File]Civil Division - U.S. Department of Justice

      https://info.5y1.org/merck-whistleblower-lawsuit_1_b12bc3.html

      Dec 12, 2013 · The second is the enactment of the Health Insurance Portability and Accountability Act, which created resources for both Inspectors General and litigation. The HHS IG referred, and continues to refer, health care fraud cases to the Civil Division. Between the whistleblower cases and the HHS IG, health care fraud recoveries have exceeded $5 billion.


    • Investor Relations | Centogene N.V.

      Non-compliance with these and other relevant laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and debarment from contracting with certain governments ...


    • [DOC File]So the wolf (of energy consumption) has walked away from ...

      https://info.5y1.org/merck-whistleblower-lawsuit_1_1b3378.html

      The lawsuit accuses Baxter of using a more dangerous and unapproved ingredient, OSCS to dilute, or to substitute for the more costly, natural ingredient in heparin to "reap greater profits as a result of utilizing cheap component parts." About 3500 pig intestines are required to produce 2.2 pounds of raw heparin.


    • [DOC File]John Q - BolenReport

      https://info.5y1.org/merck-whistleblower-lawsuit_1_37d473.html

      A third whistleblower, this one a scientist at the Centers for Disease Control, also promises to bring Merck grief following his confession of misconduct involving the same MMR vaccine. The controversies will find Merck defending itself and its vaccine in at least two federal court cases after a U.S. District judge earlier this month threw out ...


    • Lumos Pharma

      Table of Contents. UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 10-Q. Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchang


    • Investor Relations | Sutro Biopharma

      The 2018 Merck Agreement expires on a product-by-product and country-by-country basis upon the later of the expiration of the patents covering products licensed under the 2018 Merck Agreement or ten years after the first commercial sale of a product covered by the 2018 Merck Agreement. Upon expiration, Merck will have a fully paid-up, royalty ...


Nearby & related entries:

To fulfill the demand for quickly locating and searching documents.

It is intelligent file search solution for home and business.

Literature Lottery

Advertisement